Melissa Wickremasinghe is the Trust Lead for Interstitial Lung diseases and Sarcoidosis at Imperial College Healthcare NHS trust.
et al., 2014, Rituximab in severe, treatment-refractory interstitial lung disease, Respirology, Vol:19, ISSN:1323-7799, Pages:353-359
et al., 2014, Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease–related Interstitial Lung Diseases, The Journal of Rheumatology, Vol:41, ISSN:0315-162X, Pages:792-798
et al., 2013, Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials, Thorax, Vol:69, ISSN:0040-6376, Pages:428-436
et al., 2013, Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-alpha antagonist therapy, Thorax, Vol:68, ISSN:0040-6376, Pages:955-961
et al., 2012, Obstructive lung function in sarcoidosis may be missed, especially in older white patients, European Respiratory Journal, Vol:39, ISSN:0903-1936, Pages:775-777